TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 28.30
+0.08 (0.28%)
Jun 18, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 11.51 billion as of June 18, 2026.
Market Cap
11.51B
Enterprise Value
10.97B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
28.30
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 11.51B, an increase of 23.42%. That is a compound annual growth rate of 23.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 11.51B | -74.76% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 15.61B |
| TenNor Therapeutics (Suzhou) | 13.30B |
| Ascentage Pharma Group International | 11.75B |
| Nanjing Leads Biolabs | 10.66B |
| Ascletis Pharma | 10.52B |
| GenFleet Therapeutics (Shanghai) | 10.40B |
| LongBio Pharma (Suzhou) | 10.39B |
| HBM Holdings | 9.74B |